This webinar series will feature biotech industry leaders, experts, and entrepreneurs discussing COVID-19 and its impact on innovation.

In our fourth panel, hear from experts on testing strategies as well as company leaders working on testing. They'll detail current efforts & hurdles to rapidly expand efforts.

Our panelists for this event include:

Michael Mina- Assistant Professor of Epidemiology and Immunology & Infectious Disease at the Harvard School of Public Health

Dr. Mina’s research focuses on the development of novel high-throughput technologies to advance infectious disease diagnostics and epidemiological surveillance, and understand interactions between pathogen exposures and immunity. His work has uncovered prolonged effects of measles infections to delete previously acquired immunity, and has linked measles vaccines to benefits towards reducing mortality by as much as 50% globally. More broadly, a major interest of his lab is the development of molecular and mathematical tools to understand the landscape of infectious diseases and development of immunity, across ages and across the world, through the development and coupling of novel high throughput serological tools with new statistical methods. Recently, for obvious reasons, his research has taken a turn towards understanding the epidemiology and immunology relating to the novel coronavirus.

Galit Alter- Associate Professor of Medicine at Harvard Virology

Irene Bosch- CEO, CTO and Founder at E25Bio

We hope to help you see a few steps further into the future and enjoy some realistic optimism for the next few months!

Our webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast.

Innovation and Biotech in the Time of COVID-19: Testing Strategies